According to McKesson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.6259. At the end of 2021 the company had a P/E ratio of 27.6.
Year | P/E ratio | Change |
---|---|---|
2021 | 27.6 | -526.7% |
2020 | -6.48 | -77.19% |
2019 | -28.4 | -65.8% |
2018 | -83.1 | -1311.15% |
2017 | 6.86 | -58.3% |
2016 | 16.4 | -29.29% |
2015 | 23.3 | -16.97% |
2014 | 28.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Cerner CERN | 47.5 | 169.26% | ๐บ๐ธ USA |
![]() Henry Schein
HSIC | 16.7 | -5.49% | ๐บ๐ธ USA |
![]() AmerisourceBergen
ABC | 21.4 | 21.53% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | 46.7 | 165.09% | ๐บ๐ธ USA |
![]() Premier PINC | 16.6 | -5.65% | ๐บ๐ธ USA |
![]() Patterson Companies
PDCO | 13.1 | -25.60% | ๐บ๐ธ USA |
![]() Computer Programs and Systems CPSI | 22.6 | 28.49% | ๐บ๐ธ USA |
![]() Allscripts MDRX | 23.8 | 34.97% | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | -37.7 | -314.12% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.